Matthew Neil Mattson

age ~61

from El Sobrante, CA

Get Report

Also known as:

Matthew N Mattson
Matthew P Mattson
Matthew W Mattson

Phone and address:: 4368 Santa Rita Rd, Richmond, CA 94803

Connected to:

Matthew Mattson Phones & Addresses

4368 Santa Rita Rd, El Sobrante, CA 94803
El Cerrito, CA
Sunnyvale, CA
3665 Benton St, Santa Clara, CA 95051 • 4082609595
South San Francisco, CA
Osceola, IN
San Diego, CA
Esko, MN
Duluth, MN
Mountain View, CA

Work

Company:

Flashpoints on kpfa radio
Position:

Intern

Education

School / High School:

California State University- Hayward, CA
Sep 2010
Specialities:

Bachelor of Arts in Communication

Resumes

Project Engineer At Acco Engineered Systems | Leed Ap Bd+C, Cem, Ceng

view source

Position:

Project Engineer at ACCO Engineered Systems

Location:

San Francisco Bay Area

Industry:

Mechanical or Industrial Engineering

Work:

ACCO Engineered Systems - San Leandro, CA
Project Engineer
ACCO Engineered Systems - Costa Mesa, CA 2010 - 2013
Design Engineer
N.V. Heathorn - San Leandro, CA 2008 - 2010
Project Engineer
C. Overaa & Co. - Richmond, Ca 2008 - 2009
Project Engineer
J.R. Filanc - Escondido, Ca May 2007 - Aug 2007
Project Engineer Intern

Education:

California State University-Sacramento 2004 - 2009
Bachelors of Science, Mechanical Engineering, Business Administration

Languages:

Arabic

Certifications:

Certified Energy Manager (C.E.M), Association of Energy Engineers
Leadership in Energy and Environmental Design Accredited Professional (LEED AP BD+C), U.S. Green Building Council
Chartered Engineer (CEng), Institution of Mechanical Engineers (IMechE)
Engineer In Training (E.I.T.), California Board for Professional Engineers and Land Surveyors

Matthew N. Mattson

view source

Position:

Medicinal / Process Research Chemistry at Nanosyn, Senior Scientist/Project Leader - Medicinal Chemistry at Nanosyn

Location:

San Francisco Bay Area

Industry:

Pharmaceuticals

Education:

University of California, Berkeley 1994 - 1997
Post-doctoral - Prof. Henry Rapoport, Synthesis of Nicotinic/Muscarinic AgonistsÃÂ¢ÃÂÃÂ¢ÃÂ¢ÃÂÃÂ¢ Alzheimer's Therapy - Nicotinic N1-Receptor ÃÂ¢ÃÂÃÂ¢ÃÂ¢ÃÂÃÂ¢ ÃÂ¢ÃÂÃÂ¢ Synthesis of Strategic Pilocarpine Analogs. ÃÂ¢ÃÂÃÂ¢ Novel Racemic and Asymmetric Oxazolidinone Synthesis. ÃÂ¢ÃÂÃÂ¢ Imidazole Organometallic Methodology. ÃÂ¢ÃÂÃÂ¢ Novel Hemiacetal to Ketone Synthesis. ÃÂ¢ÃÂÃÂ¢ Directed chemistry for and guided 2 Ph.D. scholars University of Notre Dame 1987 - 1992
Ph.D. - Prof. Paul Helquist, Organic Synthesis - Organometallic ChemistrySynthesis, Iron Allylidene Methodology and Asymmetric Diels-Alder Reactions of Cyclopentadienyl-dicarbonyl-iron-butenone; Scale-up of cyclopropanation reagents; Selective cyclopropanations; Reactions of alkynes with carbenoids; metal-catalyzed alkene reactions; enol mesylate to vinyl iodide reactions; Uppsala universitet 1990 - 1990
Visiting Scholar, Organometallics in Organic SynthesisSelective cyclopropanation studies on palladium/sulfone chemistry substrates w/ Prof. Jan-E. Backvall

Skills:

Organic and Heterocyclic synthesis and Process Research Optimization
Medicinal Chemistry--Pharmacological and physical property optimization and high throughput methods
3-D Ligand modeling of scaffolds
comparison and evaluation
Competitive Intelligence - Patent diligence
Chiral Methodology
Parallel synthesis
Microwave-assisted organic synthesis (MAOS)
Lead optimization solubility studies
Formulation of leads

Interests:

MAOS, Heterocyclic Synthesis, Organometallic Catalysis, Asymmetric Synthesis, Unnatural Aminoacid Synthesis River and Lake Fishing, Fly Fishing Orienteering Rowling/Rowbiking Motorcycling Trail riding

Media Production Professional

view source

Location:

San Francisco Bay Area

Industry:

Media Production

Matthew Mattson Hayward, CA

view source

Work:

Flashpoints on KPFA Radio

Intern Live@The Vertex

Front of House Sound Director The Olive Garden
Hayward, CA
Server

Education:

California State University
Hayward, CA
Sep 2010 to Dec 2012
Bachelor of Arts in Communication Allan Hancock College
Santa Maria, CA
Aug 2008 to Jan 2010
Associate of Arts in Transfer Studies Ernest Righetti High School
Santa Maria, CA
Jun 2008
Diploma

Us Patents

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

7345056, Mar 18, 2008
Filed:

Aug 18, 2006
Appl. No.:

11/465726
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:

A01N 43/42
A61K 31/44
C07D 487/00
C07D 491/00
C07D 451/02
US Classification:

514304, 540477, 546124, 546112
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:.

Treatment Of Myopia
view source
US Patent:

7727544, Jun 1, 2010
Filed:

May 9, 2005
Appl. No.:

11/124673
Inventors:

Daniel M. Schwartz - San Francisco CA, US
Chang Jun Yu - Pasadena CA, US
Robert H. Grubbs - Pasadena CA, US
Julia A. Kornfield - Pasadena CA, US
Scott E. Fraser - Lacanada-flintridge CA, US
Matthew S. Mattson - Pasadena CA, US
Assignee:

The Regents of the University of California - Oakland CA
California Institute of Technology - Pasadena CA
International Classification:

A61F 2/00
A61K 31/74
US Classification:

424427, 424 7808
Abstract:

The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment and/or prevention of myopia. An activating energy source is utilized to photopolymerize or crosslink molecules in the sclera, thereby increasing the strength of the tissue. The individual is administered a crosslinking reagent or photopolymerizable molecule that becomes associated with the membrane, which is then precisely exposed to an energy source, such as light or ultrasound.

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

7754712, Jul 13, 2010
Filed:

Dec 5, 2007
Appl. No.:

11/951097
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/5365
A61K 31/437
A61K 31/4985
A61P 25/28
C07D 497/04
C07D 497/14
C07D 471/14
US Classification:

5142302, 5142305, 514250, 514293, 544101, 544105, 544346, 546 82
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:wherein A is as described in the specification and Rand Rcombine to form a [3. 3. 1] or a [3. 2. 1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3. 3. 1] or [3. 2. 1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

Pyrazolopyrrolidines As Inhibitors Of Gamma Secretase
view source
US Patent:

7977368, Jul 12, 2011
Filed:

May 21, 2008
Appl. No.:

12/124358
Inventors:

Darren Dressen - Fremont CA, US
Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Matthew N. Mattson - Santa Clara CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/40
A61K 31/4162
C07D 231/54
US Classification:

514406, 514360, 514408, 514422, 548122, 548400, 548416, 548418, 548518
Abstract:

The invention provides compounds of Formula I.

3-[4-Substituted Heterocyclyl)-Pyrrol-2-Ylmethylidene]-2- Indolinone Derivatives As Kinase Inhibitors
view source
US Patent:

20030130235, Jul 10, 2003
Filed:

Oct 10, 2002
Appl. No.:

10/268082
Inventors:

Matthew Mattson - Santa Clara CA, US
Tomas Vojkovsky - San Mateo CA, US
Congxin Liang - Sunnyvale CA, US
Peng Tang - Morago CA, US
Huiping Guan - Foster City CA, US
Assignee:

Sugen, Inc.
International Classification:

A61K031/675
A61K031/454
A61K031/404
C 07D 4 3/14
C07F009/547
US Classification:

514/080000, 514/414000, 514/323000, 548/414000, 546/201000, 548/465000
Abstract:

The present invention relates to certain 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives that inhibit kinases, in particular VEGFR and/or PDGFR kinases. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.

Indolinone Hydrazides As C-Met Inhibitors
view source
US Patent:

20060009493, Jan 12, 2006
Filed:

Jun 25, 2004
Appl. No.:

10/875508
Inventors:

Marcel Koenig - Boca Raton FL, US
Jingrong Cui - San Diego CA, US
Chung Wei - Foster City CA, US
Steven Do - San Jose CA, US
Fang-Jie Zhang - Sunnyvale CA, US
Tomas Vojkovsky - Boca Raton FL, US
John Ramphal - Union City CA, US
Guang Yang - San Ramon CA, US
Matthew Mattson - Santa Clara CA, US
Christopher Nelson - Fresno CA, US
Peng Tang - Moraga CA, US
International Classification:

C07D 43/02
A61K 31/4439
US Classification:

514339000, 546277700
Abstract:

The present invention relates to compounds of the formulae (I)-(XII), wherein R-R, A, B, X, Y, G, L and Z are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

20110003802, Jan 6, 2011
Filed:

Jul 6, 2010
Appl. No.:

12/830914
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/5383
C07D 498/06
C07D 498/16
C07D 453/02
C07D 471/16
C07D 487/06
C07D 487/16
A61K 31/439
A61K 31/4995
A61P 25/28
US Classification:

5142302, 544105, 544101, 546137, 546 82, 544349, 544346, 5142305, 514305, 514293, 514249, 514250
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:wherein A is as described in the specification and Rand Rcombine to form a [3.3.1] or a [3.2.1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3.3.1] or [3.2.1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

Bridged N-Bicyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

20110178119, Jul 21, 2011
Filed:

Aug 18, 2006
Appl. No.:

12/090616
Inventors:

Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Christopher M. Semko - Fremont CA, US
Xiaocong Michael Ye - Palo Alto CA, US
Assignee:

ELAN PHARMACEUTICALS, INC. - South San Francisco CA
International Classification:

A61K 31/439
C07D 221/02
A61P 25/28
US Classification:

514299, 546183, 546112
Abstract:

The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and Rand Rcombine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.